BFAR Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NB100-56094

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
NB100-56094
NB100-56094SS
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

This product is unpurified. The exact concentration of antibody is not quantifiable.

View all BFAR Antibodies »

Product Specifications

Immunogen

A recombinant protein corresponding to amino acids 1-139 of human BAR was used as immunogen. Human BAR is 450 amino acid protein; GenBank no. NP_057645.1.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for BFAR Antibody

Western Blot: BFAR Antibody [NB100-56094]

Western Blot: BFAR Antibody [NB100-56094]

Western Blot: BFAR Antibody [NB100-56094] - Analysis of BAR in cell lines and tissues. 25 ug of total protein was loaded per lane. BAR Recombinant protein (RP) was used as a positive control.
Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094]

Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094]

Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094] - Staining of normal Human Brain. 1:2000. A) Cerebellum. B) Medulla. A1 and B1 are higher magnifications of A and B, respectively.
Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094]

Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094]

Immunohistochemistry-Paraffin: BFAR Antibody [NB100-56094] - Staining of tumor and normal Human tissues stained for BAR expression using this antibody at 1:2000. A. Pancreatic cancer. B. Normal pancreas. C. Esophageal cancer. D. Normal esophagus. Increased expression of BAR was detected in the tumor, compared to normal tissues. Hematoxylin-eosin counterstain.

Applications for BFAR Antibody

Application
Recommended Usage

Immunohistochemistry-Paraffin

1:1000-1:5000

Immunoprecipitation

1:50-1:200

Western Blot

1:1000-1:2000

Formulation, Preparation, and Storage

Purification

Unpurified

Formulation

Whole antisera

Preservative

0.05% Sodium Azide

Concentration

This product is unpurified. The exact concentration of antibody is not quantifiable.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: BFAR

BAR (bifunctional apoptosis regulator) is a multidomain protein that was originally identified as an inhibitor of Bax-induced apoptosis (Zhang et al, 2000). Apoptosis induction can be divided up into two major pathways, extrinsic and intrinsic. The extrinsic pathway is represented by death receptor signaling and the intrinsic pathway depends on mitochondrial events. BAR is in anchored in intracellular membranes and is thought to be a scaffold protein that may bridge components of both extrinsic and intrinsic apoptosis pathways through its antiapoptotic domains: 1. BAR contains a DED-like (death effector domain) protein interaction domain that suppresses death receptor apoptosis signaling pathways. Death receptors such as the TNF-family (tumor necrosis factor) contain protein interaction domains called DD (death domains) in their cytosolic regions. DD-containing TNF receptor family members such as Fas aggregate upon binding ligand and bind to an adaptor protein FADD which contains both DD and DED domains. The Fas/FADD complexes bind to the caspase family members such as 8 and 10 which contain DEDs in their N-terminal prodomain. This is followed by proteolytic processing and caspase activation, thereby initiating a signal transduction cascade leading to activation of downstream effector caspases, substrate cleavage, and ultimate cell death. DED-containing antiapoptotic proteins like BAR function as trans dominant apoptosis inhibitors by competing for binding to the DED domains of proapoptotic proteins like FADD, caspase-8 and caspase-10, thereby preventing assembly of functional death-inducing complexes and hence activation of downstream apoptosis signaling cascades. 2. BAR also contains a domain that mediates interactions with Bcl-2 family proteins and that is required for suppression of Bax-induced cell death in yeast and mammalian cells. Although the physiological functions of BAR remain to be elucidated. BAR is highly expressed in the brain and expression patterns as well as functional data with neuronal cell lines suggest that BAR is involved in regulating neuronal survival (Roth et al. 2003). Additionally, subcellular localization studies indicate that BAR predominantly localizes to the endoplasmic reticulum (ER), irrespective of cell type. Bcl-2 family proteins also localize to the ER. There is important crosstalk between the ER and mitochondria in the execution of cell death. It is thought that both BAR and Bcl-2 proteins play a role in regulating cell death/apoptosis induced by ER stress. Dysregulation of ER homeostasis and apoptosis is thought to be involved in the pathogenesis of some human neuronal diseases, including Alzheimer's, Parkinson's, polyglutamine diseases, neuronal storage diseases, prion diseases, as well as acute neurodegeneration from brain trauma (reviewed in Lindholm et al, 2006). Since BAR is normally widely expressed in the brain, it may have a cytoprotective function in helping neurons to survive for the entire lifetime of the organism by playing a central role in inhibiting ER initiated apoptosis.

Alternate Names

BARRNF47RING finger protein 47, bifunctional apoptosis inhibitor, bifunctional apoptosis regulator

Entrez Gene IDs

51283 (Human)

Gene Symbol

BFAR

Additional BFAR Products

Product Documents for BFAR Antibody

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Download SDS

Product Specific Notices for BFAR Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.